Curat Global LLC Invests $242,000 in HCA Healthcare, Inc. (NYSE:HCA)

Curat Global LLC acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 700 shares of the company's stock, valued at approximately $242,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in HCA. Whipplewood Advisors LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at $31,000. Tidemark LLC bought a new position in shares of HCA Healthcare during the 4th quarter valued at $36,000. Activest Wealth Management grew its holdings in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after purchasing an additional 125 shares during the last quarter. Legacy Investment Solutions LLC grew its holdings in shares of HCA Healthcare by 99.0% during the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after purchasing an additional 95 shares during the last quarter. Finally, Physician Wealth Advisors Inc. bought a new position in shares of HCA Healthcare during the 4th quarter valued at $64,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

Insiders Place Their Bets

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer now directly owns 12,646 shares of the company's stock, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.30% of the company's stock.

Analyst Ratings Changes

Several research firms recently commented on HCA. Baird R W lowered shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Royal Bank of Canada cut their price target on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Monday, April 28th. Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Finally, Barclays set a $416.00 price target on shares of HCA Healthcare and gave the stock an "overweight" rating in a report on Monday, June 2nd. Seven research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $388.80.

HCA Healthcare Stock Up 0.8%

NYSE HCA traded up $3.02 during trading hours on Friday, reaching $384.52. 619,646 shares of the company's stock traded hands, compared to its average volume of 1,440,692. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The firm has a market cap of $92.51 billion, a PE ratio of 17.50, a PEG ratio of 1.10 and a beta of 1.49. The firm has a 50-day simple moving average of $355.28 and a 200 day simple moving average of $331.72. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The company had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. During the same period last year, the company posted $5.36 EPS. HCA Healthcare's revenue was up 5.7% on a year-over-year basis. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.75%. HCA Healthcare's dividend payout ratio (DPR) is presently 12.81%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.